emeis (EMEIS) Q4 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 TU earnings summary
17 Apr, 2026Executive summary
2025 marked a turning point with strong business recovery, operational targets exceeded, and a sustainably improved balance sheet, driven by restructuring and quality improvements since 2022.
Revenue grew 6.1% organically, with occupancy rates rising to 87.6% and clear evidence of operational turnaround.
Customer and resident satisfaction reached record highs, with a 93.5% satisfaction rate and NPS of 41, reflecting restored trust and improved service quality.
Major disposals and refinancing initiatives led to a €1 billion reduction in net debt and leverage ratio improvement from 19.5x to 10.0x.
Financial highlights
Revenue reached €5,895 million (+6.1% organic), with strong contributions from nursing homes and international operations.
EBITDAR rose 19.2% at constant perimeter, and EBITDA (excl. IFRS 16) increased 56.5% year-over-year.
Free cash flow turned positive at €342 million, a €640 million improvement from last year.
Net debt (pro forma Isemia) reduced by €1 billion to €3.77 billion; leverage ratio improved to 10.0x from 19.5x.
Disposals since mid-2022 totaled €2.45 billion, exceeding the €1.5 billion target.
Outlook and guidance
Midterm guidance reiterated: EBITDAR CAGR of 12%-16% and revenue CAGR of 4%-5% at constant perimeter through 2028.
For 2026, EBITDAR expected to grow at least 10% like-for-like.
Conservative assumptions for public funding in France, with self-help measures driving further improvement.
Latest events from emeis
- Strong 2025 recovery: revenue +6.1%, EBITDAR +19.2%, net debt down €1bn, outlook positive.EMEIS
H2 20259 Apr 2026 - 2024 results beat guidance with strong margin recovery and €916m in asset disposals.EMEIS
Q4 2024 TU29 Dec 2025 - EBITDAR and EBITDA exceeded guidance as revenue, margins, and occupancy improved in 2024.EMEIS
H2 202425 Dec 2025 - Q3 2025 saw strong organic growth, high occupancy, and a positive outlook for 2025.EMEIS
Q3 2025 TU10 Dec 2025 - Organic sales up 6.2% and occupancy rates rise, supporting robust 2025 EBITDAR outlook.EMEIS
Q1 202525 Nov 2025 - Strong organic growth, margin expansion, and disposals drive robust recovery and outlook.EMEIS
H1 20253 Oct 2025 - Revenue and margins surged, disposals and leverage reduction exceeded targets.EMEIS
Q2 2025 TU1 Aug 2025 - Revenue up 9.2%, net loss narrows, and debt falls as recovery and disposals accelerate.EMEIS
H1 202413 Jun 2025 - Revenue up 9.2% in H1 2024, but EBITDAR outlook cut amid slow French recovery.EMEIS
Q2 2024 TU13 Jun 2025